Trial Profile
A Phase I trial of INBRX-111 to treat Pseudomonas Infections
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2017
Price :
$35
*
At a glance
- Drugs INBRX-111 (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions
- 07 Nov 2017 New trial record